Wartość Dochody organizacji Acceleron Pharma Inc to -$254.85
Dochód netto dostępny dla zwykłych akcjonariuszy jest równy dochodzie netto pomniejszonemu o wypłatę uprzywilejowanych dywidend.
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.